Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Pharmacogenomic Submissions Final Guidance To Be Issued In March

This article was originally published in The Pink Sheet Daily

Executive Summary

The guidance has cleared the agency's Office of the Chief Counsel, FDA's Lawrence Lesko tells the Drug Information Association meeting in Lisbon, Portugal. FDA will launch a pharmacogenomics website the week of March 14 that will include information on "what's going on with voluntary submissions," Lesko says.

Related Content

Topics

UsernamePublicRestriction

Register

PS061931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel